CAITLIN MYERS: Open Payments
NPI 1235566738 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,399 in 52 payments from 12 companies in 2025. Trend: 2023 $1,063 · 2024 $679 · 2025 $1,399
Food & beverage: $1,264Education: $135
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 18 | $379 |
| MILLICENT US INC | 7 | $245 |
| Astellas Pharma US Inc | 7 | $211 |
| Exeltis, USA Inc. | 3 | $133 |
| Sumitomo Pharma America, Inc. | 3 | $77 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $69 |
| Organon LLC | 2 | $64 |
| PFIZER INC. | 2 | $60 |
| Exact Sciences Corporation | 3 | $57 |
| Biogen, Inc. | 2 | $55 |
Products named: Veozah, SLYND, ANNOVERA, INTRAROSA, MYFEMBREE, ABRYSVO, Cologuard Collection Kit, ZURZUVAE.
Industry payments across NY — which companies pay providers there.
